Where Will Orkla India Share Price Be in the Next 3 Years?

The Orkla India share price forecast for the next 3 years is a question on many investors’ minds as the stock trades at Rs 570, within a 52 week range of Rs 533 to Rs 760. This article lays out a scenario based Orkla India share price outlook for 2027, 2028 and 2030, built on the company’s fundamentals, sector trends and the key risks that could change the trajectory. Rather than a single number, the focus here is on the range of outcomes and the assumptions behind each one.

Click Here – Get Free Investment Predictions

Orkla India Company Overview

Orkla India manufactures health and nutrition products including chyawanprash, glucose and healthcare foods under the Dabur brand through a licensing arrangement, having listed in 2025. Understanding the business model is the first step in framing any credible Orkla India share price forecast, because the durability of earnings ultimately decides where the stock trades.

Company	Orkla India
NSE Ticker	ORKLAINDIA
CMP	Rs 570
52 Week High	Rs 760
52 Week Low	Rs 533
Market Cap	Rs 7,801 Cr
Stock PE	26.2
Book Value	Rs 201
ROE	11.4%
ROCE	15.2%
Dividend Yield	0%

Where Does Orkla India Share Price Stand Today?

The stock currently trades about 25 percent below its 52 week high of Rs 760, which means the market has already tempered some of its optimism. For anyone building a Orkla India share price forecast, this correction matters for the Orkla India share price forecast starting point, because entry valuations have a large bearing on 3 year returns.

At the current price, Orkla India commands a market capitalisation of Rs 7,801 Cr and trades at a price to earnings multiple of 26.2. The company generates a return on equity of 11.4% and a return on capital employed of 15.2%, which places it in the category of businesses with moderate return ratios. These numbers anchor the Orkla India share price forecast scenarios that follow. How the broader Nifty 50 index trades over this period will also influence the multiple investors are willing to assign to the stock.

Orkla India Share Price Forecast: Key Growth Drivers for the Next 3 Years

Four forces are likely to shape the Orkla India share price forecast between now and 2030, and together they explain most of the dispersion in this Orkla India share price forecast. Each is discussed below with its likely direction of impact.

Earnings Trajectory and Return Ratios

Stock prices ultimately follow earnings. With moderate return ratios at present, the pace at which profits compound over FY27 to FY30 will be the single biggest determinant of the Orkla India share price forecast actually playing out. Consistent earnings delivery tends to expand valuation multiples, while misses compress them quickly.

Consumption Recovery and Rural Demand Tailwinds

FMCG demand is recovering as rural incomes improve, inflation cools and government spending supports consumption. Distribution expansion and premiumisation give branded players such as Orkla India multiple levers to convert category growth into earnings. Sector trends are visible in the Nifty FMCG index, which serves as a useful barometer for the space.

Within the space, investors often benchmark Orkla India against peers such as Navneet Education, Kokuyo Camlin and Linc on growth and valuations before forming a view on the Orkla India share price forecast.

Company Specific Catalysts

The bull case for Orkla India rests on rising health and nutrition product demand and brand support from the Dabur licensing relationship. If these play out on schedule, the Orkla India share price forecast for 2030 could gravitate toward the upper end of the scenario range discussed below.

Macro Environment and Liquidity

The RBI rate cycle, FII flows into Indian equities and overall market valuations will influence the multiple investors are willing to pay. A benign macro backdrop supports the optimistic end of any Orkla India share price forecast, while global risk aversion would do the opposite to the Orkla India share price outlook.

Orkla India Share Price Forecast 2027, 2028 and 2030: Scenario Analysis

The table below presents a scenario based Orkla India share price forecast using compounded annual growth assumptions applied to the current market price of Rs 570. These are illustrative ranges, not point predictions, and actual outcomes can fall outside them.

Year	Bear Case	Base Case	Bull Case	Assumption
2027	Rs 605	Rs 655	Rs 710	4% to 16% CAGR on CMP
2028	Rs 630	Rs 725	Rs 825	4% to 16% CAGR on CMP
2030	Rs 680	Rs 875	Rs 1,110	4% to 16% CAGR on CMP

In the base case scenario of this Orkla India share price forecast, the 2030 level works out to roughly Rs 875, implying steady compounding from today’s levels. The bull case of Rs 1,110 assumes rising health and nutrition product demand and brand support from the Dabur licensing relationship delivers ahead of expectations, while the bear case of Rs 680 captures a scenario where growth stalls. That is an outcome band of about 19 percent to 95 percent over the period.

Consult a SEBI Registered Investment Advisor Before Acting on Any Forecast

Bull Case vs Bear Case for Orkla India Share Price

The Bull Case

The optimistic Orkla India share price forecast assumes rising health and nutrition product demand and brand support from the Dabur licensing relationship. Combined with supportive sector conditions, this could lift both earnings and the valuation multiple, pushing the stock toward Rs 1,110 by 2030.

The Bear Case

The cautious view centres on the fact that dependence on the Dabur brand licensing arrangement and competition from other health food brands are key risks. If these pressures dominate, the Orkla India share price forecast would skew toward the lower band and the stock could stagnate near Rs 680 even by 2030, underperforming broader indices.

Key Risks That Could Change the Orkla India Share Price Outlook

• Execution risk: Delays in strategy execution or capacity plans would push the earnings trajectory below the base case assumed in this Orkla India share price forecast.
• Valuation risk: At a PE of 26.2, any earnings disappointment can trigger sharp multiple compression before fundamentals stabilise.
• Sector risk: Dependence on the Dabur brand licensing arrangement and competition from other health food brands are key risks.
• Macro risk: A global slowdown, adverse FII flows or unexpected rate moves would compress equity valuations across the market.
• Regulatory risk: Policy, tax or compliance changes affecting the sector can alter the earnings outlook with little warning.

Is Orkla India Worth Watching for the Long Term?

For long term investors, the relevant question is not just where the Orkla India share price forecast lands in 2030 or what any single Orkla India share price forecast says today, but whether the business can compound capital through cycles. The company’s positioning around rising health and nutrition product demand and brand support from the Dabur licensing relationship gives it a credible growth story, while the risks outlined above define what must be monitored each quarter.

Investors should track quarterly earnings, management commentary and sector data rather than anchoring to any single number from a Orkla India share price outlook. Historically, staying focused on business fundamentals has served investors better than chasing price targets, and consulting a SEBI registered advisor before investing remains the prudent approach.

Download the Univest iOS App or Univest Android App to track Orkla India share price live.

Conclusion

The Orkla India share price forecast for the next 3 years spans Rs 680 to Rs 1,110 by 2030 under the scenarios discussed, with a base case near Rs 875. Any credible Orkla India share price forecast must be updated as facts change, and the path will be decided by earnings delivery, rising health and nutrition product demand and brand support from the Dabur licensing relationship and the broader market environment. Treat these ranges as a framework for thinking, not a promise of outcomes, and revisit the assumptions as new results come in. Consult a SEBI registered investment advisor before making any investment decision.

What is the Orkla India share price forecast for the next 3 years?

Ans. The Orkla India share price forecast for the next 3 years is scenario based rather than a single number. By 2030, the illustrative range spans Rs 680 in the bear case to Rs 1,110 in the bull case, with a base case near Rs 875, depending on earnings delivery and market conditions.

What is the Orkla India share price forecast for 2027?

Ans. For 2027, the scenario range works out to Rs 605 to Rs 710, with a base case around Rs 655. This assumes compounding on the current price of Rs 570 and is illustrative, not a guaranteed outcome.

What is the Orkla India share price forecast for 2028?

Ans. The 2028 scenario range is Rs 630 to Rs 825, with the base case near Rs 725. Actual levels will depend on earnings growth, sector trends and overall market valuations at the time.

What is the current share price of Orkla India?

Ans. Orkla India currently trades at around Rs 570 on the NSE, within a 52 week range of Rs 533 to Rs 760. Prices change continuously during market hours, so check live quotes before acting.

Is Orkla India a good stock for the long term?

Ans. Orkla India has a credible long term story built on rising health and nutrition product demand and brand support from the Dabur licensing relationship, but it also carries risks since dependence on the Dabur brand licensing arrangement and competition from other health food brands are key risks. Long term suitability depends on your risk profile and portfolio, so consult a SEBI registered investment advisor before investing.

What is the Orkla India share price outlook for 2030?

Ans. The Orkla India share price outlook for 2030 spans Rs 680 to Rs 1,110 across bear and bull scenarios. Where the stock actually lands will be driven by profit growth, valuation multiples and macro conditions closer to that date.

What are the key risks to the Orkla India share price forecast?

Ans. The main risks are execution delays, valuation compression from the current PE of 26.2, sector specific pressures, macro shocks and regulatory changes. Any of these can push the stock below the base case scenario discussed in this article.